Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
•
Hospital Medicine
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
Related Questions
What is the stepwise investigation of patients suspected of inflammatory myopathy?
Which non-pharmacologic treatments for neuropathic pain have you found most effective?
Do you recommend plasmapheresis for treatment of patients with osmotic demyelination?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?
In a patient with acute stroke/ICH/SDH/hyperammonemia at risk for rebound edema with new onset renal failure, do you prefer CRRT versus low and slow HD? How frequently do you monitor osmolarity?
Which methods of tracking response to treatment in myasthenia gravis do you find most helpful?
What is your approach to management of patients with cerebral edema in the setting of hypoxic-ischemic injury?
How do you use amantadine and assess its efficacy for comatose pediatric patients?
What is your approach to managing patients who initially present with symptomatic intracranial large vessel occlusion but subsequently experience resolution of symptoms or become non-disabling before any intervention?
